You are currently viewing a new version of our website. To view the old version click .

Biomarkers and Rapid Microbiological Techniques for Optimizing the Diagnosis and Treatment of Patients with Sepsis

This special issue belongs to the section “Microbiology in Human Health and Disease“.

Special Issue Information

Dear Colleagues,

In recent years, there have been advances in the use of laboratory techniques to improve the early recognition of sepsis.  Some of these involve the discovery or evaluation of biomarkers or digital signatures of sepsis in order to improve the timeliness and accuracy of diagnosis or new therapeutic targets.

Rapid diagnosis and appropriate antibiotic therapies are essential and have been shown to improve survival. Despite the importance of early detection, current technologies and clinical methods are often insufficient because they lack the necessary speed, specificity or sensitivity.

Given the complexity of sepsis treatment, there is a need for rapid microbiological diagnostic panels that, combined with clinical data and biomarker profiles, allow for the early optimization of empirical antibiotic treatment.

Regarding the scope of this Special Issue on biomarkers and rapid microbiological diagnostic techniques, the authors should offer attractive research perspectives on the utility and impact of using different types of biomarkers or rapid microbiological identification panels in patients with sepsis.

Dr. Alejandro Rodriguez
Dr. Frederic Francesc Gómez-Bertomeu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • sepsis biomarkers
  • rapid microbiological detection
  • rapid AST
  • PCR-multiplex technique
  • molecular diagnosis
  • mass spectrometry technology
  • DNA hybridization
  • microarrays
  • rapid PCR-based test

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059